Evidence map›Paper›PMID 23027540›Full record

ArticleInfection and immunity2012

Microbial amyloids induce interleukin 17A (IL-17A) and IL-22 responses via Toll-like receptor 2 activation in the intestinal mucosa.

Jessalyn H Nishimori, Tiffanny N Newman, Gertrude O Oppong, Glenn J Rapsinski, Jui-Hung Yen, Steven G Biesecker, R Paul Wilson, Brian P Butler, Maria G Winter, Renee M Tsolis and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Biofilm-associated molecular patterns: BAMPs.Infection and immunity · 2025
    Review
  8. Review
  9. Review
  10. Review
  11. Dysbiosis and Alzheimer's disease: role of probiotics, prebiotics and synbiotics.Naunyn-Schmiedeberg's archives of pharmacology · 2023
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jessalyn H NishimoriDepartment of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
Tiffanny N Newman
Gertrude O Oppong
Glenn J Rapsinski
Jui-Hung Yen
Steven G Biesecker
R Paul Wilson
Brian P Butler
Maria G Winter
Renee M Tsolis
Doina Ganea
Çagla Tükel
Temple University · USUniversity of California, Davis · US

Funding

Vaccine strategy for broad spectrum protection agains non-typhoidal salmonellU54AI057168 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2003 to 2013
$91.5M
REGULATION OF IMMUNE CELL APOPTOSIS BY NEUROPEPTIDESR01AI047325 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI GANEA, DOINA · 2001 to 2014
$3.8M
Characterization of the Brucella virB locusR01AI050553 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI TSOLIS, RENEE M · 2001 to 2010
$2.9M
Role of PGE2 in CNS and peripheral autoimmune disordersR01AI052306 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI GANEA, DOINA · 2003 to 2010
$2.7M
CB2 Receptor Regulatin of Inflammatory Response in EAER01AI084065 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI GANEA, DOINA, TUMA, RONALD F · 2009 to 2012
$1.5M
Mechanisms of Salmonella Bacteremia in Pediatric MalariaR21AI082320 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TSOLIS, RENEE M · 2010 to 2011
$405k
Neuropeptides and Regulatory T CellsR56AI047325 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI GANEA, DOINA · 2008 to 2008
$297k
NIAID NIH HHS AI047325NIAID NIH HHS AI050553NIAID NIH HHS AI052306NIAID NIH HHS AI082320NIAID NIH HHS AI084065NIAID NIH HHS R01 AI047325NIAID NIH HHS R01 AI050553NIAID NIH HHS R01 AI052306NIAID NIH HHS R01 AI084065NIAID NIH HHS R21 AI082320NIAID NIH HHS R56 AI047325NIAID NIH HHS U54 AI057168NIAID NIH HHS U54 AI57168
6 · The paper itself

Abstract

The Toll-like receptor 2 (TLR2)/TLR1 receptor complex responds to amyloid fibrils, a common component of biofilm material produced by members of the phyla Firmicutes, Bacteroidetes, and Proteobacteria. To determine whether this TLR2/TLR1 ligand stimulates inflammatory responses when bacteria enter intestinal tissue, we investigated whether expression of curli amyloid fibrils by the invasive enteric pathogen Salmonella enterica serotype Typhimurium contributes to T helper 1 and T helper 17 responses by measuring cytokine production in the mouse colitis model. A csgBA mutant, deficient in curli production, elicited decreased expression of interleukin 17A (IL-17A) and IL-22 in the cecal mucosa compared to the S. Typhimurium wild type. In TLR2-deficient mice, IL-17A and IL-22 expression was blunted during S. Typhimurium infection, suggesting that activation of the TLR2 signaling pathway contributes to the expression of these cytokines. T cells incubated with supernatants from bone marrow-derived dendritic cells (BMDCs) treated with curli fibrils released IL-17A in a TLR2-dependent manner in vitro. Lower levels of IL-6 and IL-23 production were detected in the supernatants of the TLR2-deficient BMDCs treated with curli fibrils. Consistent with this, three distinct T-cell populations-CD4(+) T helper cells, cytotoxic CD8(+) T cells, and γδ T cells-produced IL-17A in response to curli fibrils in the intestinal mucosa during S. Typhimurium infection. Notably, decreased IL-6 expression by the dendritic cells and decreased IL-23 expression by the dendritic cells and macrophages were observed in the cecal mucosa of mice infected with the curli mutant. We conclude that TLR2 recognition of bacterial amyloid fibrils in the intestinal mucosa represents a novel mechanism of immunoregulation, which contributes to the generation of inflammatory responses, including production of IL-17A and IL-22, in response to bacterial entry into the intestinal mucosa.

Indexed as

AmyloidAnimalsCells, CulturedColitisDisease Models, AnimalFemaleHT29 CellsHumansInterleukin-17Interleukin-22InterleukinsIntestinal MucosaMiceMice, Inbred BALB CSalmonella typhimuriumTh17 CellsAmyloidInterleukin-17Interleukin-22InterleukinsTlr2 protein, mouseToll-Like Receptor 2

Identifiers

PMID23027540
PMCPMC3497426
OpenAlexW2087055632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.